Upstream Bio, Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| – | +534.3% | +311.0% | -26.6% | |
| – | +539.1% | +309.6% | -26.6% | |
| – | +51.5% | +1,161.5% | -68.8% | |
| – | +544.0% | +328.4% | -27.4% | |
| – | -42.7% | +400.0% | -43.4% | |
| – | +92.8% | -95.1% | +18.0% | |
| – | +34.2% | +64.8% | +25.3% | |
| – | -48.3% | +1,464.4% | +2.3% | |
| – | +179.5% | +103.1% | -32.5% | |
| – | – | – | -27.7% | |
| – | – | – | – | |
| – | +0.0% | +41.3% | +4.9% |
Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.